Advertisement

Locally Advanced Differentiated Thyroid Cancer

  • Ming Yann Lim
  • Mark Zafereo
  • Elizabeth GrubbsEmail author
Chapter

Abstract

Well-differentiated thyroid carcinoma (WDTC) comprises the majority (>90 %) of thyroid cancers [1], with 10–15 % presenting as locally advanced [2, 3]. Locally advanced thyroid cancers are those that extend beyond the thyroid capsule to invade surrounding structures, including muscles, recurrent laryngeal nerve(s), trachea, larynx, esophagus, and major blood vessels in the neck and chest. McCaffrey et al. described 262 patients with locally advanced papillary thyroid carcinoma (PTC) treated over a 60-year period at the Mayo Clinic; sites of invasion included the muscle (53 %), trachea (37 %), recurrent laryngeal nerve (47 %), esophagus (21 %), larynx (12 %), and other sites (30 %) [4]. Su et al. recently published a contemporary review of 69 patients with WDTC invading the upper aerodigestive tract, reporting complete tumor excision with negative margins in 62 % of patients. The authors showed 85 % locoregional control, with 23 % of patients developing distant metastases, and 5-year overall survival 71 % [5].

Keywords

Thyroid Cancer Papillary Thyroid Carcinoma Recurrent Laryngeal Nerve External Beam Radiation Therapy Cricoid Cartilage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Sherman SI. Thyroid carcinoma. Lancet (London, England). 2003;361(9356):501–11.CrossRefGoogle Scholar
  2. 2.
    Shaha AR. Thyroidectomy for locally advanced cancer. In: Duh W-Y, editor. Atlas of endocrine surgical techniques. 1st ed. Philadelphia: Saunders; 2010. p. 25–46. Townsend and Evers.Google Scholar
  3. 3.
    Shindo ML, Caruana SM, Kandil E, McCaffrey JC, Orloff LA, Porterfield JR, et al. Management of invasive well-differentiated thyroid cancer: an American Head and Neck Society consensus statement. AHNS consensus statement. Head Neck. 2014;36(10):1379–90.PubMedGoogle Scholar
  4. 4.
    McCaffrey JC. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology. Laryngoscope. 2006;116(1):1–11.CrossRefPubMedGoogle Scholar
  5. 5.
    Su SY, Milas ZL, Bhatt N, Roberts D, Clayman GL. Well-differentiated thyroid cancer with aerodigestive tract invasion: long-term control and functional outcomes. Head Neck. 2016;38(1):72–8. doi: 10.1002/hed.23851. Epub 2015 Apr 6.6.CrossRefPubMedGoogle Scholar
  6. 6.
    Ortiz S, Rodriguez JM, Soria T, Perez-Flores D, Pinero A, Moreno J, et al. Extrathyroid spread in papillary carcinoma of the thyroid: clinicopathological and prognostic study. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg. 2001;124(3):261–5.CrossRefGoogle Scholar
  7. 7.
    Andersen PE, Kinsella J, Loree TR, Shaha AR, Shah JP. Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg. 1995;170(5):467–70.CrossRefPubMedGoogle Scholar
  8. 8.
    Fujimoto Y, Obara T, Ito Y, Kodama T, Yashiro T, Yamashita T, et al. Aggressive surgical approach for locally invasive papillary carcinoma of the thyroid in patients over forty-five years of age. Surgery. 1986;100(6):1098–107.PubMedGoogle Scholar
  9. 9.
    Grillo HC, Zannini P. Resectional management of airway invasion by thyroid carcinoma. Ann Thorac Surg. 1986;42(3):287–98.CrossRefPubMedGoogle Scholar
  10. 10.
    Melliere DJ, Ben Yahia NE, Becquemin JP, Lange F, Boulahdour H. Thyroid carcinoma with tracheal or esophageal involvement: limited or maximal surgery? Surgery. 1993;113(2):166–72.PubMedGoogle Scholar
  11. 11.
    Park CS, Suh KW, Min JS. Cartilage-shaving procedure for the control of tracheal cartilage invasion by thyroid carcinoma. Head Neck. 1993;15(4):289–91.CrossRefPubMedGoogle Scholar
  12. 12.
    McCaffrey TV, Bergstralh EJ, Hay ID. Locally invasive papillary thyroid carcinoma: 1940–1990. Head Neck. 1994;16(2):165–72.CrossRefPubMedGoogle Scholar
  13. 13.
    Czaja JM, McCaffrey TV. The surgical management of laryngotracheal invasion by well-differentiated papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 1997;123(5):484–90.CrossRefPubMedGoogle Scholar
  14. 14.
    Kowalski LP, Filho JG. Results of the treatment of locally invasive thyroid carcinoma. Head Neck. 2002;24(4):340–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Shaha AR. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope. 2004;114(3):393–402.CrossRefPubMedGoogle Scholar
  16. 16.
    Breaux Jr GP, Guillamondegui OM. Treatment of locally invasive carcinoma of the thyroid: how radical? Am J Surg. 1980;140(4):514–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Ballantyne AJ. Resections of the upper aerodigestive tract for locally invasive thyroid cancer. Am J Surg. 1994;168(6):636–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Frankenthaler RA, Sellin RV, Cangir A, Goepfert H. Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am J Surg. 1990;160(4):341–3.CrossRefPubMedGoogle Scholar
  19. 19.
    Wada N, Masudo K, Hirakawa S, et al. Superior vena cava (SVC) reconstruction using autologous tissue in two cases of differentiated thyroid carcinoma presenting with SVC syndrome. World J Surg Oncol. 2009;7:75.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Michael E. Kupferman, Randal S. Weber. Surgical management of locally advanced thyroid cancer. In: RE Pollack, editor. Advanced therapy in surgical oncology. 2008 BC Decker INC. Ontario: PMPH-USA; 2008. p. 353–60.Google Scholar
  21. 21.
    Friedman M. Surgical management of thyroid carcinoma with laryngotracheal invasion. Otolaryngol Clin North Am. 1990;23(3):495–507.PubMedGoogle Scholar
  22. 22.
    Shin DH, Mark EJ, Suen HC, Grillo HC. Pathologic staging of papillary carcinoma of the thyroid with airway invasion based on the anatomic manner of extension to the trachea: a clinicopathologic study based on 22 patients who underwent thyroidectomy and airway resection. Hum Pathol. 1993;24(8):866–70.CrossRefPubMedGoogle Scholar
  23. 23.
    Nishida T, Nakao K, Hamaji M. Differentiated thyroid carcinoma with airway invasion: indication for tracheal resection based on the extent of cancer invasion. J Thorac Cardiovasc Surg. 1997;114(1):84–92.CrossRefPubMedGoogle Scholar
  24. 24.
    Ozaki O, Sugino K, Mimura T, Ito K. Surgery for patients with thyroid carcinoma invading the trachea: circumferential sleeve resection followed by end-to-end anastomosis. Surgery. 1995;117(3):268–71.CrossRefPubMedGoogle Scholar
  25. 25.
    Tsukahara K, Sugitani I, Kawabata K. Surgical management of tracheal shaving for papillary thyroid carcinoma with tracheal invasion. Acta Otolaryngol. 2009;129:1498–502.CrossRefPubMedGoogle Scholar
  26. 26.
    Patel KN, Shaha AR. Locally advanced thyroid cancer. Curr Opin Otolaryngol Head Neck Surg. 2005;13(2):112–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Yu P, Clayman GL, Walsh GL. Human tracheal reconstruction with a composite radial forearm free flap and prosthesis. Ann Thorac Surg. 2006;81(2):714–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Yu P, Clayman GL, Walsh GL. Long-term outcomes of microsurgical reconstruction for large tracheal defects. Cancer. 2011;117(4):802–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Machens A, Hinze R, Lautenschlager C, Thomusch O, Dralle H. Thyroid carcinoma invading the cervicovisceral axis: routes of invasion and clinical implications. Surgery. 2001;129(1):23–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Gillenwater AM, Goepfert H. Surgical management of laryngotracheal and esophageal involvement by locally advanced thyroid cancer. Semin Surg Oncol. 1999;16(1):19–29.CrossRefPubMedGoogle Scholar
  31. 31.
    Falk SA, McCaffrey TV. Management of the recurrent laryngeal nerve in suspected and proven thyroid cancer. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg. 1995;113(1):42–8.CrossRefGoogle Scholar
  32. 32.
    Nishida T, Nakao K, Hamaji M, Kamiike W, Kurozumi K, Matsuda H. Preservation of recurrent laryngeal nerve invaded by differentiated thyroid cancer. Ann Surg. 1997;226(1):85–91.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Sanuki T, Yumoto E, Minoda R, Kodama N. The role of immediate recurrent laryngeal nerve reconstruction for thyroid cancer surgery. J Oncol. 2010;2010:846235.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Yumoto E, Sanuki T, Kumai Y. Immediate recurrent laryngeal nerve reconstruction and vocal outcome. Laryngoscope. 2006;116(9):1657–61.CrossRefPubMedGoogle Scholar
  35. 35.
    Wang W, Chen D, Chen S, Li D, Li M, Xia S, et al. Laryngeal reinnervation using ansa cervicalis for thyroid surgery-related unilateral vocal fold paralysis: a long-term outcome analysis of 237 cases. PLoS One. 2011;6(4):e19128.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Gardner RE, Tuttle RM, Burman KD, Haddady S, Truman C, Sparling YH, et al. Prognostic importance of vascular invasion in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2000;126(3):309–12.CrossRefPubMedGoogle Scholar
  37. 37.
    Kebebew E, Clark OH. Locally advanced differentiated thyroid cancer. Surg Oncol. 2003;12(2):91–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Lee YS, Chung WY, Chang HS, Park CS. Treatment of locally advanced thyroid cancer invading the great vessels using a Y-shaped graft bypass. Interact Cardiovasc Thorac Surg. 2010;10(6):1039–41.CrossRefPubMedGoogle Scholar
  39. 39.
    Wada N, Masudo K, Hirakawa S, Woo T, Arai H, Suganuma N, et al. Superior vena cava (SVC) reconstruction using autologous tissue in two cases of differentiated thyroid carcinoma presenting with SVC syndrome. World J Surg Oncol. 2009;7:75.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Thompson NW, Brown J, Orringer M, Sisson J, Nishiyama R. Follicular carcinoma of the thyroid with massive angioinvasion: extension of tumor thrombus to the heart. Surgery. 1978;83(4):451–7.PubMedGoogle Scholar
  41. 41.
    Lalak NJ, Campbell PR. Infiltrating papillary carcinoma of the thyroid with macroscopic extension into the internal jugular vein. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg. 1997;117(6):S228–30.CrossRefGoogle Scholar
  42. 42.
    Lee YS, Chung WY, Chang HS, Park CS. Treatment of locally advanced thyroid cancer invading the great vessels using a Y-shaped graft bypass. Interact Cardiovasc Thorac Surg. 2010;10:1039–41.CrossRefPubMedGoogle Scholar
  43. 43.
    Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. doi: 10.1089/thy.2015.0020.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Pena C, Molnar I, Schlumberger MJ. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet. 2014;384:319–28.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Leboulleux S, Bastholt L, Krause T, de la Fouchardiere C, Tennvall J, Awada A, Gomez JM, Bonichon F, Leenhardt L, Soufflet C, Licour M, Schlumberger MJ. Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial. Lancet Oncol. 2012;13:897–905.CrossRefPubMedGoogle Scholar
  46. 46.
    Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, Habra MA, Newbold K, Shah MH, Hoff AO, Gianoukakis AG, Kiyota N, Taylor MH, Kim SB, Krzyzanowska MK, Dutcus CE, de las Heras B, Zhu J, Sherman SI. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med. 2015;372:621–30.CrossRefPubMedGoogle Scholar
  47. 47.
    Chow SM, Yau S, Kwan CK, Poon PC, Law SC. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition. Endocr Relat Cancer. 2006;13(4):1159–72.CrossRefPubMedGoogle Scholar
  48. 48.
    Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer. 1998;82(2):375–88.CrossRefPubMedGoogle Scholar
  49. 49.
    Sheline GE, Galante M, Lindsay S. Radiation therapy in the control of persistent thyroid cancer. Am J Roentgenol Radium Ther Nucl Med. 1966;97(4):923–30.CrossRefPubMedGoogle Scholar
  50. 50.
    O’Connell ME, A’Hern RP, Harmer CL. Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital. Eur J Cancer (Oxford, England: 1990). 1994;30A(6):733–9.CrossRefGoogle Scholar
  51. 51.
    Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A. Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg. 2006;30(5):780–6.CrossRefPubMedGoogle Scholar
  52. 52.
    McConahey WM, Hay I, Woolner LB, van Heerden JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clinic Proc. In: Edge SE, Byrd D, Compton CC, et al., editors. AJJ cancer staging manual. 7th ed. New York: Springer; 2009.Google Scholar
  53. 53.
    Tovi F, Goldstein J. Locally aggressive differentiated thyroid carcinoma. J Surg Oncol. 1985;29(2):99–104.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Ming Yann Lim
    • 1
  • Mark Zafereo
    • 2
  • Elizabeth Grubbs
    • 3
    Email author
  1. 1.Department of OtolaryngologyTan Tock Seng HospitalSingaporeSingapore
  2. 2.Departments of Head and NeckUniversity of Texas MD Anderson Cancer CenterHoustonUSA
  3. 3.Departments of Surgical OncologyUniversity of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations